Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation

Molecular and Cellular Biology

Volumn 30, Issue 4, 2010, Pages 1041-1048

  Jung, Yong Sam ^a   Liu, Gang ^a   Chen, Xinbin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE ETA; PROTEASOME; PROTEIN P53; PROTEIN PIRH2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; RING FINGER MOTIF; SKIN CANCER; ULTRAVIOLET IRRADIATION; XERODERMA PIGMENTOSUM;

APOPTOSIS; CELL LINE; DNA-DIRECTED DNA POLYMERASE; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; UBIQUITIN-PROTEIN LIGASES;

EID: 75749108557     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01198-09     Document Type: Article

References (33)

1. Abbas, T., U. Sivaprasad, K. Terai, V. Amador, M. Pagano, and A. Dutta. 2008. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 22:2496-2506.
2. Bienko, M., C. M. Green, N. Crosetto, F. Rudolf, G. Zapart, B. Coull, P. Kannouche, G. Wider, M. Peter, A. R. Lehmann, K. Hofmann, and I. Dikic. 2005. Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science 310:1821-1824.
3. Chau, V., J. W. Tobias, A. Bachmair, D. Marriott, D. J. Ecker, D. K. Gonda, and A. Varshavsky. 1989. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243:1576-1583.
4. Chowdary, D. R., J. J. Dermody, K. K. Jha, and H. L. Ozer. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14:1997-2003.
5. Duan, S., Z. Yao, D. Hou, Z. Wu, W. G. Zhu, and M. Wu. 2007. Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. EMBO J. 26:3062-3074.
6. Goldberg, A. L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426:895-899.
7. Guo, C., J. N. Kosarek-Stancel, T. S. Tang, and E. C. Friedberg. 2009. Y-family DNA polymerases in mammalian cells. Cell. Mol. Life Sci. 66:2363-2381.
8. Hattori, T., T. Isobe, K. Abe, H. Kikuchi, K. Kitagawa, T. Oda, C. Uchida, and M. Kitagawa. 2007. Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Cancer Res. 67:10789-10795.
9. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
10. Hershko, A. 1996. Lessons from the discovery of the ubiquitin system. Trends Biochem. Sci. 21:445-449.
11. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
12. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.
13. Jin, Y., H. Lee, S. X. Zeng, M. S. Dai, and H. Lu. 2003. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J. 22:6365-6377.
14. Kannouche, P., and A. Stary. 2003. Xeroderma pigmentosum variant and error-prone DNA polymerases. Biochimie 85:1123-1132.
15. Kawamoto, T., K. Araki, E. Sonoda, Y. M. Yamashita, K. Harada, K. Kikuchi, C. Masutani, F. Hanaoka, K. Nozaki, N. Hashimoto, and S. Takeda. 2005. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol. Cell 20:793-799.
16. Kim, S. H., and W. M. Michael. 2008. Regulated proteolysis of DNA polymerase eta during the DNA-damage response in C. elegans. Mol. Cell 32:757-766.
17. Kruse, J. P., and W. Gu. 2009. Modes of p53 regulation. Cell 137:609-622.
18. Lee, H., S. X. Zeng, and H. Lu. 2006. UV induces p21 rapid turnover independently of ubiquitin and Skp2. J. Biol. Chem. 281:26876-26883.
19. Leng, R. P., Y. Lin, W. Ma, H. Wu, B. Lemmers, S. Chung, J. M. Parant, G. Lozano, R. Hakem, and S. Benchimol. 2003. Pirh2, a p53-induced ubiquitinprotein ligase, promotes p53 degradation. Cell 112:779-791.
20. Liu, G., and X. Chen. 2006. DNA polymerase , the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation. Mol. Cell. Biol. 26:1398-1413.
21. Logan, I. R., V. Sapountzi, L. Gaughan, D. E. Neal, and C. N. Robson. 2004. Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome. J. Biol. Chem. 279:11696-11704.
22. Masutani, C., R. Kusumoto, A. Yamada, N. Dohmae, M. Yokoi, M. Yuasa, M. Araki, S. Iwai, K. Takio, and F. Hanaoka. 1999. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399:700-704.
23. McIlwraith, M. J., A. Vaisman, Y. Liu, E. Fanning, R. Woodgate, and S. C. West. 2005. Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination. Mol. Cell 20: 783-792.
24. Murata, S., H. Yashiroda, and K. Tanaka. 2009. Molecular mechanisms of proteasome assembly. Nat. Rev. Mol. Cell Biol. 10:104-115.
25. Oren, M., W. Maltzman, and A. J. Levine. 1981. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1:101-110.
26. Plosky, B. S., A. E. Vidal, A. R. Fernandez de Henestrosa, M. P. McLenigan, J. P. McDonald, S. Mead, and R. Woodgate. 2006. Controlling the subcellular localization of DNA polymerases iota and eta via interactions with ubiquitin. EMBO J. 25:2847-2855.
27. Sdek, P., H. Ying, D. L. Chang, W. Qiu, H. Zheng, R. Touitou, M. J. Allday, and Z. X. Xiao. 2005. MDM2 promotes proteasome-dependent ubiquitinindependent degradation of retinoblastoma protein. Mol. Cell 20:699-708.
28. Sheng, Y., R. C. Laister, A. Lemak, B. Wu, E. Tai, S. Duan, J. Lukin, M. Sunnerhagen, S. Srisailam, M. Karra, S. Benchimol, and C. H. Arrowsmith. 2008. Molecular basis of Pirh2-mediated p53 ubiquitylation. Nat. Struct. Mol. Biol. 15:1334-1342.
29. Stoyanova, T., T. Yoon, D. Kopanja, M. B. Mokyr, and P. Raychaudhuri. 2008. The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol. Cell. Biol. 28:177-187.
30. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1015-1068.
31. Vousden, K. H., and C. Prives. 2009. Blinded by the light: the growing complexity of p53. Cell 137:413-431.
32. Zhang, Z., H. Wang, M. Li, S. Agrawal, X. Chen, and R. Zhang. 2004. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J. Biol. Chem. 279:16000-16006.
33. Zheng, G., J. Ning, and Y. C. Yang. 2007. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53. Biochem. Biophys. Res. Commun. 364:344-350.